Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $45.1400 (-0.81%) ($44.8300 - $45.1400) on Fri. Jun. 25, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.24% (three month average) | RSI | 71 | Latest Price | $45.1400(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 1.8% a day on average for past five trading days. | Weekly Trend | HALO advances 3.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(50%) IWM(49%) IWC(46%) IWN(45%) | Factors Impacting HALO price | HALO will decline at least -1.12% in a week (0% probabilities). VIXM(-30%) VXX(-11%) UUP(-11%) GLD(-1%) TLT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.12% (StdDev 2.24%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $43.78(3.11%) | 10 Day Moving Average | $43.29(4.27%) | 20 Day Moving Average | $41.91(7.71%) | To recent high | -11.8% | To recent low | 16.2% | Market Cap | $6.169b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |